An interventional study of Robot-assisted total knee arthroplasty and Conventional total knee arthroplasty in Knee Arthroplasty, Total, Robotic-assisted and Osteoarthritis of the Knee, sponsored by Danderyd Hospital. Recruiting at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by Danderyd Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 2nd largest by planned enrollment of the 38 interventional ones that give a count, is one of 5 that started in 2024, is one of 23 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 44th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:
Vastra Gotaland Region · Sites in Sweden
Ages 30+
Vastra Gotaland Region · Sites in Sweden
Ages 18+
Uppsala University · Sites in Sweden
Ages 18–100
Region Skane · Sites in Sweden
Ages 25+
Linkoeping University · Sites in Sweden
Ages 40–85
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 6 · Phase 3 7
First in 2005; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,600 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 175 across the 38 interventional studies, 246 across the 16 observational. Of the 30 that completed or were terminated, 8 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 54 have an industry lead sponsor. The 10 most frequent:
Danderyd Hospital is the lead sponsor of 60 studies on the registry; 13 are open to participants now.
Danderyd Hospital has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
5 of the studies in Osteoarthritis, Knee with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05584410Vastra Gotaland RegionDigitalization of Osteoarthritis Care | 2026-12-31 |
| NCT07212920Vastra Gotaland RegionValidity and Reliability of Video-Based Functional Physiotherapy Assessment of Subacute Knee Injuries | 2026-12-31 |
| NCT06459700Lund UniversityEffect of Probiotic Supplements on Osteoarthritis Outcomes | 2027-04-30 |
| NCT07875647Mälardalen UniversityPerson-Centred Digital Rehabilitation for Knee Osteoarthritis | 2027-09 |
| NCT07383740Vastra Gotaland RegionTest-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Rationale for conducting the study:
The ROCKET study evaluates the clinical and economic outcomes of robot-assisted total knee arthroplasty (RTKR) compared with conventional total knee arthroplasty (TKR). The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Secondary outcomes include patient-reported knee function, health-related quality of life, self-reported instability, physical activity, radiographic alignment, surgical and technical outcomes, complications, reoperations, revisions, and health-economic outcomes.
Study design:
International multicentre, preference-tolerant, randomized, controlled superiority trial with two treatment arms comparing RTKR with conventional TKR. Participants in the randomized part are allocated 1:1. At selected centres where feasible, an optional participant-blinded randomized component may be implemented. Eligible patients who do not undergo randomization may participate in a parallel observational/preference cohort, which is analysed separately from the primary randomized comparison.
Study population:
Adults aged 18 years and older who are eligible for total knee arthroplasty according to local guidelines and who provide informed consent.
Number of patients:
Up to 1,600 randomized participants. Eligible non-randomized participants may additionally be included in the observational/preference cohort.
Primary outcome:
Proportion of randomized participants achieving FJS ≥80 points at 24 months after surgery.
Long-term follow-up:
Patient-reported and registry-based outcomes are planned at 5 and 10 years after surgery where feasible.
The ROCKET study is an international multicentre, prospective, preference-tolerant randomized controlled superiority trial comparing robot-assisted total knee arthroplasty with conventional total knee arthroplasty.
Participants in the randomized component are allocated 1:1 to robot-assisted or conventional total knee arthroplasty. Randomization is stratified by participating centre and sex. At selected centres where practical and approved, participants may remain blinded to treatment allocation until completion of the 24-month follow-up unless earlier unblinding is clinically required or requested by the participant. Surgeons and operating-room personnel cannot be blinded. Outcome assessment is performed blinded to treatment allocation whenever feasible.
Eligible patients who are unwilling to undergo randomization, or for whom treatment equipoise cannot be achieved, may enter a parallel observational/preference cohort. Treatment in this cohort follows patient and surgeon preference. The observational/preference cohort is analysed separately from the primary randomized comparison.
The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Follow-up includes patient-reported outcomes, activity, radiographic alignment, surgical and technical variables, complications, reoperations, revisions and health-economic outcomes. Long-term follow-up is planned at 5 and 10 years after surgery, including PROMs where available and registry-based outcomes such as reoperations, revisions, complications and mortality.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Robot-assisted total knee arthroplasty (RTKR).
Procedure: Robot-assisted total knee arthroplasty
Conventional total knee arthroplasty (TKR).
Procedure: Conventional total knee arthroplasty
Robot-assisted total knee arthroplasty using an approved robotic surgical system to assist intraoperative planning, bone preparation, implant positioning and balancing according to the participating centre's approved technique.
Conventional total knee arthroplasty using standard manual instrumentation according to local clinical routine.
Proportion of participants achieving a Forgotten Joint Score (FJS) ≥80 points
The primary endpoint is the proportion of randomized participants achieving an FJS of ≥80 points at 24 months after surgery. The FJS ranges from 0 to 100, with higher scores indicating less awareness of the replaced knee during everyday activities.
Time frame: 24 months after surgery
Forgotten Joint Score (FJS), continuous score
FJS is scored from 0 to 100, with higher scores indicating less awareness of the replaced knee.
Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee injury and Osteoarthritis Outcome Score (KOOS)
KOOS assesses knee-related pain, symptoms, activities of daily living, sport/recreation and knee-related quality of life. Each subscale ranges from 0 to 100, with higher scores indicating better outcome.
Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Self-reported knee instability (ADLS items)
Self-reported slipping/partial giving way and buckling/full giving way are assessed using items from the Activities of Daily Living Scale of the Knee Outcome Survey.
Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
EQ-5D and EQ VAS
Health-related quality of life is assessed using EQ-5D and EQ VAS.
Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Patient activity and walking distance
Patient activity and walking distance are assessed during follow-up using the study's prespecified activity measurements.
Time frame: Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee alignment
Coronal knee alignment is assessed using long-standing radiographs, including Hip-Knee-Ankle alignment and Coronal Plane Alignment of the Knee (CPAK) classification.
Time frame: Preoperative and approximately 6 weeks after surgery
Surgery time
Duration of the surgical procedure is recorded in minutes.
Time frame: During the index operation
Technical and intraoperative surgical outcomes
Technical difficulties and prespecified intraoperative surgical details are recorded.
Time frame: During the index operation
Range of motion (ROM)
Knee range of motion is assessed at the 24-month follow-up.
Time frame: 24 months after surgery
Reoperations and revisions
Reoperations and revisions of the index knee are recorded during the primary study period and assessed during long-term follow-up where data are available.
Time frame: Up to 24 months, with additional follow-up at 5 and 10 years
Adverse events and complications
Adverse events and complications related to the index knee arthroplasty are recorded. Long-term complications may additionally be assessed using approved registry or other data sources.
Time frame: Up to 24 months, with additional long-term assessment at 5 and 10 years
Mortality
Mortality is assessed using available approved registry or other data sources.
Time frame: 90 days, 1 year, 5 years and 10 years after surgery
Health-economic outcomes
Health-economic analyses include direct and indirect costs and cost-effectiveness using health-related quality-of-life data.
Time frame: Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2024 (actual). Primary completion is estimated for Dec 2029, 69 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 69 months is above that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Danderyd Hospital